SCHEMBL2432098

SCHEMBL2432098

NC(=O)C1(CC(c2ccccc2)N2CCCCC2)CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.53
CYP2C19 P33261 6/20 0.53
CYP2C9 P11712 5/20 0.53
HPGD P15428 2/20 0.53
MAPK1 P28482 1/20 0.53
CYP3A4 P08684 5/20 0.49
CYP2D6 P10635 5/20 0.49
TSHR P16473 3/20 0.49
GAA P10253 2/20 0.46
LMNA P02545 2/20 0.43
ALDH1A1 P00352 4/20 0.42
KCNA5 P22460 4/20 0.41
KCNH2 Q12809 4/20 0.41
KCNE1 P15382 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
GLA P06280 1/20 0.41
OPRL1 P41146 3/20 0.41
OPRD1 P41143 3/20 0.40
OPRM1 P35372 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2432526 1.00 CYP1A2 (0.53) CYP1A2CYP2C19CYP2C9HPGDMAPK1
SCHEMBL224843 0.79 SLC6A3 (0.54) CYP1A2CYP2C19CYP2C9HPGDMAPK1
SCHEMBL518234 0.77 MME (0.39) CYP1A2CYP2C19MAPK1CYP2D6TSHR
SCHEMBL6266551 0.77 CYP1A2 (0.70) CYP1A2CYP2C19CYP2C9HPGDMAPK1
SCHEMBL6472115 0.74 MME (0.37) KMT2AMEN1OPRK1
SCHEMBL5538602 0.74 MME (0.39) CYP1A2CYP2D6LMNAALDH1A1KMT2A
SCHEMBL535200 0.74 CYP2D6 (0.38) CYP1A2CYP2C19MAPK1CYP2D6TSHR
SCHEMBL2404618 0.73 CYP1A2 (0.57) CYP1A2CYP2C19CYP2C9HPGDMAPK1
SCHEMBL4855890 0.73 CYP1A2 (0.74) CYP1A2CYP2C19CYP2C9HPGDMAPK1
Hydrochloric Acid SCHEMBL6926712 0.73 MME (0.39) CYP1A2CYP2D6LMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389720-B2 Quinolone neuropeptide S receptor antagonists MERCK SHARP & DOHME CORP. (US) 2013-03-05 US disclosed
US-20110212946-A1 Quinolone Neuropeptide S Receptor Antagonists MERCK SHARP & DOHME LLC 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212946-A1 Quinolone Neuropeptide S Receptor Antagonists NPSR1, NPY1R, NPY2R CYP1A2 3279/4885CYP2C19 2738/4885CYP2C9 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.